Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Carvana
CVNA
|
+$1.01B |
| 2 |
Microsoft
MSFT
|
+$727M |
| 3 |
Amazon
AMZN
|
+$478M |
| 4 |
PayPal
PYPL
|
+$450M |
| 5 |
Apple
AAPL
|
+$448M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$800M |
| 2 |
Invesco Dorsey Wright Momentum ETF
PDP
|
+$610M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$483M |
| 4 |
Boston Scientific
BSX
|
+$211M |
| 5 |
Fidelity High Dividend ETF
FDVV
|
+$205M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.35% |
| 2 | Financials | 6.13% |
| 3 | Consumer Discretionary | 6.04% |
| 4 | Healthcare | 5.03% |
| 5 | Communication Services | 4.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5001
First Trust NASDAQ-100 Technology Index Fund
QTEC
$4.41B
| $45K | ﹤0.01% |
257
-759
| -75% | -$130K |
|
5002
Solid Biosciences
SLDB
$785M
| $45K | ﹤0.01% |
1,714
+1,245
| +265% | +$38K |
|
5003
Tyra Biosciences
TYRA
$1.84B
| $45K | ﹤0.01% |
3,165
+2,725
| +619% | +$54.1K |
|
5004
Wave Life Sciences
WVE
$1.13B
| $45K | ﹤0.01% |
14,383
+6,225
| +76% | +$25.8K |
|
|
NAGE
5005
Niagen Bioscience
NAGE
$262M
| $45K | ﹤0.01% |
11,937
+6,598
| +124% | +$35.6K |
|
|
ATCO
5006
DELISTED
Atlas Corp.
ATCO
| $45K | ﹤0.01% |
3,181
+1,893
| +147% | +$26.8K |
|
|
LOTZ
5007
DELISTED
CarLotz, Inc. Class A Common Stock
LOTZ
| $45K | ﹤0.01% |
19,623
+8,154
| +71% | +$26.7K |
|
|
MSP
5008
DELISTED
Datto Holding Corp.
MSP
| $45K | ﹤0.01% |
1,712
-256
| -13% | -$6.22K |
|
5009
CorMedix
CRMD
$577M
| $44K | ﹤0.01% |
9,644
+5,327
| +123% | +$26.4K |
|
5010
Citius Pharmaceuticals
CTXR
$13.7M
| $44K | ﹤0.01% |
1,153
+619
| +116% | +$28.1K |
|
5011
Flexsteel Industries
FLXS
$317M
| $44K | ﹤0.01% |
1,641
+54
| +3% | +$1.55K |
|
|
FPF
5012
First Trust Intermediate Duration Preferred & Income Fund
FPF
$1.08B
| $44K | ﹤0.01% |
1,805
-3,324
| -65% | -$82.8K |
|
5013
NN Inc
NNBR
$261M
| $44K | ﹤0.01% |
10,654
+5,381
| +102% | +$26.4K |
|
|
FRBK
5014
DELISTED
Republic First Bancorp Inc
FRBK
| $44K | ﹤0.01% |
11,888
+6,370
| +115% | +$21.4K |
|
|
MTEM
5015
DELISTED
Molecular Templates, Inc.
MTEM
| $44K | ﹤0.01% |
741
+423
| +133% | +$31.7K |
|
5016
AerSale
ASLE
$307M
| $43K | ﹤0.01% |
2,440
+1,392
| +133% | +$26K |
|
5017
Direxion Daily Healthcare Bull 3X ETF
CURE
$194M
| $43K | ﹤0.01% |
300
-100
| -25% | -$12.1K |
|
|
GORV
5018
DELISTED
Lazydays
GORV
| $43K | ﹤0.01% |
67
+39
| +139% | +$24.4K |
|
5019
Nathan's Famous
NATH
$407M
| $43K | ﹤0.01% |
734
+394
| +116% | +$24.1K |
|
5020
Vitamin Cottage Natural Grocers
NGVC
$744M
| $43K | ﹤0.01% |
3,032
+1,118
| +58% | +$14.3K |
|
5021
Silicom
SILC
$219M
| $43K | ﹤0.01% |
831
-592
| -42% | -$26.3K |
|
|
ITI
5022
DELISTED
Iteris, Inc.
ITI
| $43K | ﹤0.01% |
10,717
+5,899
| +122% | +$28.5K |
|
|
HARP
5023
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| $43K | ﹤0.01% |
575
+193
| +51% | +$13.2K |
|
5024
CuriosityStream
CURI
$145M
| $42K | ﹤0.01% |
7,163
+3,613
| +102% | +$30.4K |
|
5025
Dianthus Therapeutics
DNTH
$5.55B
| $42K | ﹤0.01% |
587
+186
| +46% | +$18.7K |
|
Similar funds
Citigroup's Q4 2021 Portfolio in Review
As of Q4 2021, Citigroup held 6,293 positions worth $187B, up 10% from $169B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Citigroup deployed $6.91B of net new capital in Q4 2021, opening 489 new positions and adding to 2,934 existing holdings. Its largest new stake was Nu Holdings: 27,608,577 shares worth $259M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 11% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $800M trimmed.
- Citigroup's largest Q4 2021 buy was Nu Holdings: 27,608,577 shares worth $259M.
- Citigroup added most to Carvana in Q4 2021, an estimated $1.01B increase.
- Citigroup's biggest Q4 2021 reduction was Invesco QQQ Trust, cutting an estimated $800M.
- Citigroup fully exited ProShares UltraPro Short QQQ in Q4 2021, selling an estimated $149M.
- Citigroup's ten largest holdings make up 25% of its $187B portfolio in Q4 2021.
- Citigroup opened 489 new positions and closed 426 in Q4 2021.
- Citigroup's portfolio value rose 10% quarter-over-quarter to $187B.
Based on Citigroup's 13F filing for Q4 2021, filed 10 Feb 2022.